Építés alatt – nem éles oldal
Belépés
Csak meghívásosFázis nélkül

A Study of Wearable Device in Essential Tremor Patients

A legfontosabb adatok

Hol
Rochester (Egyesült Államok)A helyszín megnézése

Helyszínek itt: Egyesült Államok

  • Mayo Clinic MinnesotaRochester, Egyesült ÁllamokNo longer taking part

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

A vizsgálat adatai

Ki végzi
Mayo Clinic
Azonosító
NCT05976074
A regiszteradat frissítve
2026. október 2.
Eredeti leírás
The purpose of this research is to observe the daily loss of benefit from DBS therapy by performing a standardized set of tasks throughout the day while wearing an Apple Watch to collect movement and other physiological data.A teljes eredeti leírásKevesebb

A Prospective Feasibility Study Evaluating the Use of Wearable Devices to Quantify Tolerance to Deep Brain Stimulation in Essential Tremor Patients

The purpose of this research is to observe the daily loss of benefit from DBS therapy by performing a standardized set of tasks throughout the day while wearing an Apple Watch to collect movement and other physiological data.

Bevonási feltételek: Patients with well-classified essential tremor, who are already receiving regular DBS therapy at Mayo Clinic for their movement disorder; Ability to understand study procedures and to comply with them for the entire length of the study and use study devices as outlined in protocol; Patient agrees to perform daily tasks in BrainRISE app and consents to the study collecting video and audio recordings during those tasks; Proficient in the use of a smart phone.

Kizáró feltételek: Cognitive or psychiatric condition rendering a patient unable to cooperate with data collection, or to manage and recharge smart watch and tablet computer devices; Presence of open or healing wounds near monitoring sites (infection risk); Inability or unwillingness of individual or legal guardian/representative to give written informed consent.

ClinicalTrials.gov NCT05976074